DW 2008
Alternative Names: DW-2008; DW2008SLatest Information Update: 28 Jul 2024
At a glance
- Originator Dong Wha Pharmaceutical
- Developer Dong Wha Pharmaceutical; Institut Pasteur Korea
- Class Antiasthmatics; Antivirals
- Mechanism of Action Cytokine inhibitors; TIGIT protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Rhinitis
- No development reported Allergic asthma; COVID 2019 infections
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for phase-I development in Allergic-asthma(In volunteers) in South Korea (PO, Tablet)
- 28 Jul 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in South Korea (PO)
- 28 Jul 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in South Korea (PO)